A new anti-MRSA antibiotic complex, WAP-8294A II. Structure characterization of minor components by ESI LCMS and MS/MS

Journal of Antibiotics

Volumn 64, Issue 5, 2011, Pages 373-379

  Kato, Azusa ^a   Hirata, Haruhisa ^a   Ohashi, Yoshitami ^b   Fujii, Kiyonaga ^c   Mori, Kenji ^c   Harada, Ken Ichi ^c  

^a Wakamoto Pharmaceutical Co Ltd   (Japan)

^b aRigen Pharmaceuticals Incorporated   (Japan)

^c MEIJO UNIVERSITY   (Japan)

Author keywords

anti methicillin resistant Staphylococcus aureus agent; depsipeptide; ESI; tandem MS; WAP 8294

Indexed keywords

ALANINE; ANTIBIOTIC AGENT; ASPARAGINE; DEXTRO THREO BETA HYDROXYASPARAGINE; FATTY ACID; GLUTAMINE; GLYCINE; LEUCINE; OCTANOIC ACID; SERINE; TRYPTOPHAN; UNCLASSIFIED DRUG; VALINE; VANCOMYCIN; WAP 8249A; WAP 8294 A; WAP 8294A1; WAP 8294A2; WAP 8294A4; WAP 8294AX13;

AMINO ACID SEQUENCE; ANTIMICROBIAL ACTIVITY; ARTICLE; CHIRALITY; DRUG ISOLATION; FERMENTATION; FRAGMENTATION REACTION; LYSOBACTER; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; PRIORITY JOURNAL;

AMINO ACID SEQUENCE; ANTI-BACTERIAL AGENTS; DEPSIPEPTIDES; FERMENTATION; LYSOBACTER; MAGNETIC RESONANCE SPECTROSCOPY; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; STAPHYLOCOCCAL INFECTIONS; TANDEM MASS SPECTROMETRY;

LYSOBACTER SP.; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS;

EID: 79957609228     PISSN: 00218820     EISSN: 18811469     Source Type: Journal    
DOI: 10.1038/ja.2011.9     Document Type: Article

References (23)

1. Chambers, H. F. Methicillin resistance in staphylococci: molecular and biochemical basis and clinical implications. Clin. Microbiol. Rev. 10, 781-791 (1997). (Pubitemid 27477734)
2. Grundmann, H., Aires-de-Sousa, M., Boyce, J. & Tiemersma, E. Emergence and resurgence of methicillin-resistant Staphylococcus aureus as a public-health threat. Lancet 368, 874-885 (2006). (Pubitemid 44308640)
3. Hiramatsu, K. et al. Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. J. Antimicrob. Chemother. 40, 135-136 (1997). (Pubitemid 27341646)
4. Steinkraus, G., White, R. & Friedrich, L. Vancomycin MIC creep in non-vancomycin-intermediate Staphylococcus aureus (VISA), vancomycin-susceptible clinical methicil-lin-resistant S. aureus (MRSA) blood isolates from 2001-5. J. Antimicrob. Chemother. 60, 788-794 (2007). (Pubitemid 47434257)
5. Arias, C. A. & Murray, B. E. Antibiotic-resistant bugs in the 21st century-a clinical super-challenge. N. Engl. J. Med. 360, 439-443 (2009).
6. Livermore, D. M. Quinupristin/dalfopristin and linezolid: where, when, which and whether to use? J. Antimicrob. Chemother. 46, 347-350 (2000).
7. Ford, C. W., Zurenko, G. E. & Barbachyn, M. R. The discovery of linezolid, the first oxazolidinone antibacterial agent. Curr. Drug Targets Infect. Disord. 1, 181-199 (2001).
8. Debono, M. et al. A21978C, a complex of new acidic peptide antibiotics: isolation, chemistry, and mass spectral structure elucidation. J. Antibiot. 40, 761-777 (1987). (Pubitemid 17086227)
9. Pirri, G., Giuliani, A., Nicoletto, S. F., Pizzuto, L. & Rinaldi, A. C. Lipopeptides as anti-infectives: a practical perspective. Cent. Eur. J. Biol. 4, 258-273 (2009).
10. Kato, A. et al. A new anti-MRSA antibiotic complex, WAP-8294A I. Taxonomy, isolation, and biological activities. J. Antibiot. 51, 929-935 (1998). (Pubitemid 28505287)
11. Kato, A. et al. WAP-8294A2, a novel anti-MRSA antibiotic produced by Lysobacter sp. J. Am. Chem. Soc. 119, 6680-6681 (1997). (Pubitemid 27322352)
12. Biemann, K. & Martin, A. S. Mass spectrometric determination of the amino acid sequence of peptides and proteins. Mass Spectrom. Rev. 6, 1-75 (1987).
13. Papayannopulos, A. I. The interpretation of collision-induced dissociation tandem mass spectra of peptides. Mass Spectrom. Rev. 14, 49-73 (1995).
14. Fujii, K. et al. A non-empirical method using LC/MS for determination of the absolute configuration of constituent amino acids in a peptide: elucidation of limitations of Marfey's method and its separation mechanism. Anal. Chem. 69, 3346-3352 (1997).
15. Fujii, K., Ikai, Y., Oka, H., Suzuki, M. & Harada, K.-I. A non-empirical method using LC/MS for determination of the absolute configuration of constituent amino acids in a peptide: combination of Marfey's method with mass spectrometry and its practical application. Anal. Chem. 69, 5146-5151 (1997)
16. Harada, K.-I. et al. Application of D, L-FDLA derivatization to determination of absolute configuration of constituent amino acids in peptide by advanced Marfey's method. Tetrahedron Lett. 37, 3001-3004 (1996). (Pubitemid 26139667)
17. Jegorov, A., Havlicek, V. & Sedmera, P. Rapid screening of destruxins by liquid chromatography/mass spectrometry. J. Mass Spectrom. 33, 274-280 (1998). (Pubitemid 28144339)
18. Harada, K.-I. et al. Co-production of microcystins and aeruginopeptins by natural cyanobacterial blooms. Environ. Toxicol 16, 298-305 (2001). (Pubitemid 32734202)
19. Fujii, K. et al. Mass spectrometric studies of peptides from cyanobacteria under FAB MS/MS conditions. J. Mass Spectrom. Soc. Jpn. 48, 56-64 (2000).
20. Ishiyama, D. et al. Glomosporin, a novel antifungal cyclic depsipeptide from Glomos-pora sp. II. Structure elucidation. J. Antibiot. 53, 525-531 (2000). (Pubitemid 30345271)
21. n technique. Rapid Commun. Mass Spectrom. 21, 1025-1033 (2007). (Pubitemid 46426824)
22. Fritzsche, K., Lenz, W. R. & Fuller, C. R. Bacterial polyesters containing branched poly(beta-hydroxyalkanoate) units. Int. J. Biol. Macromol. 12, 92-101 (1990). (Pubitemid 20273958)
23. Nakagawa, Y. & Matsuyama, T. Chromatographic determination of optical configuration of 3-hydroxy fatty acids composing microbial surfactants. FEMS Microbiol. Lett. 108, 99-102 (1993). (Pubitemid 23093474)